CLINICAL_TRIALS
research
· 2025-12-29
Clinical Trial Update: FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy [Phase 3]
Summary
A Phase 3 FIREFLY trial evaluating fenofibrate as first-line therapy for Primary Biliary Cholangitis is currently recruiting. The trial is sponsored by Xijing H…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cholangitis (PBC) | Phase 3 | Status: RECRUITING